1.
Rev. invest. clín
; Rev. invest. clín;73(2): 61-64, Mar.-Apr. 2021. tab, graf
Artigo
em Inglês
|
LILACS-Express
| LILACS
| ID: biblio-1251864
2.
Rev Invest Clin
; 2021 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33428609
RESUMO
In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated disease coronavirus disease 2019 (COVID-19), hypoxemia mechanisms differ from those observed in acute respiratory distress syndrome. Hypoxemia and respiratory failure in COVID- 19 are attributed to pulmonary angiopathy, increasing physiological pulmonary shunting1-3.